Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:124-130
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rothenburger, M.
Right arrow Articles by Scheld, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rothenburger, M.
Right arrow Articles by Scheld, H. H.

The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery

Markus Rothenburger, MD*, Rasjid Soeparwata, MD*, Mario C. Deng, MD, FACC, FESC{dagger}, Elmar Berendes, MD{ddagger}, Christof Schmid, MD*, Tonny D. T. Tjan*, Markus J. Wilhelm, MD*, Michael Erren, MD§, Dirk Böcker, MD|| and Hans Heinrich Scheld, MD*

* Department of Cardiothoracic Surgery, University of Muenster, Muenster, Germany
{dagger} Heart Failure Center, Columbia University, New York, New York, USA
{ddagger} Department of Anesthesiology and Operative Intensive Care, University of Muenster, Muenster, Germany
§ Institute for Clinical Laboratory Medicine, University of Muenster, Muenster, Germany
|| Department of Cardiology and Angiology, University of Muenster, Muenster, Germany



View larger version (35K):

[in a new window]
 
Figure 1 Time course of anti-endotoxin core antibodies perioperatively in patients undergoing coronary artery bypass graft surgery without adverse events (groups 1A and 1B) compared with that in patients with prolonged mechanical ventilation time (group 2) (mean value ± SD). Time points: 1) preoperative; 2) induction of anesthesia; 3) sternotomy; 4) cardiopulmonary bypass onset; 5) protamine reversal; 6) skin closure; 7) 30 min postoperatively; 8) 3 h postoperatively; 9) 24 h postoperatively; 10) 48 h postoperatively; and 11) 72 h postoperatively. *p < 0.01. Ig = immunoglobulin; LPS = lipopolysaccharide.

 


View larger version (17K):

[in a new window]
 
Figure 2 Time course of endotoxin levels perioperatively in patients undergoing coronary artery bypass graft surgery requiring ventilation time <12 h (group 1A); 12 to 24 h (group 1B) and >24 h (prolonged ventilation; group 2) (mean value ± SD). Time points are described in Figure 1. *p < 0.001.

 


View larger version (24K):

[in a new window]
 
Figure 3 Time course of interleukin-8 perioperatively in patients undergoing coronary artery bypass graft surgery requiring ventilation time <12 h (group 1A), 12 to 24 h (group 1B) and >24 h (prolonged ventilation; group 2) (mean value ± SD). Time points are described in Figure 1. *p < 0.001.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement